CDMO service

CDMO service
Product Description

[Oncology CDMO Service for Cytotoxic Injectables]

Product: Lyophilized Vials, Liquid Vials

[Current Plant]

- Certification: EU GMP, JGMP, KGMP, PIC/s

- Production: Cytotoxic APIs, Cytotoxic Injectables (Liquid, Lyophilized vials) 

- Capacity: 10~200L as bulk solution

- Range of Vials: 0.5~50mL 


[New Pharmaceutical Plant] *construction will be completed by end of 2020*

- Certification: Expected to achieve cGMP certification

- Production: Cytotoxic Injectables (Liquid, Lyophilized vials) 

- Capacity: 30~300L as bulk solution


- Range of Vials: 0.5~50mL 





*Full dossiers for EU and Japan*

-Paclitaxel

-Oxaliplatin

-Docetaxel

Other formulations of oncology injectables possible

Approved in EU and Japan


I

Samyang Biopharmaceuticals Corp

  • KR
  • 2016
    On CPHI since

Samyang Biopharmaceuticals Corp

  • KR
  • 2016
    On CPHI since

More Products from Samyang Biopharmaceuticals Corp (2)

  • APIs

    Product APIs

    [Cytotoxic APIs] 

    Paclitaxel Produced by fermentation
    Paclitaxel Produced by a semi-synthetic process
    Docetaxel, anhydrous 
    Pemetrexed
    Bortezomib
    Cabazitaxel 


    Package: Up to 500g per request




    *If you need further information on our APIs, re...
  • FDFs

    Product FDFs

    Oncology products:
    Genexol PM (Paclitaxel)
    Nanoxel M (Docetaxel)
    Zolenic (Zoledronic acid)
    Injectables (Paclitaxel, Docetaxel, Oxaliplatin)
    Patch Products:
    Fentaderm (Fentanyl)
    Demencure (Rivastigmine)
    Nicostop (Nicotine)
    Rheumastop (Diclofenac Diethylammonium)
    Anigderm (Nitrogly...

Samyang Biopharmaceuticals Corp resources (2)